Tyler Perfitt

Tyler Perfitt, Ph.D., is a Scientist in Neuroscience Biology at Atalanta Therapeutics, where responsibilities include developing high-throughput screens for protein analysis and leading a project with Target ALS and The Jackson Laboratory. Previous experience includes a Postdoctoral Researcher role at Pfizer, focusing on Friedreich's ataxia, and a short-term postdoctoral position at Vanderbilt University, which involved studying synaptic scaffolding proteins. Tyler Perfitt obtained a Ph.D. in Molecular Physiology and Biophysics from Vanderbilt University and a BA in Biology and Spanish from DePauw University. Research experience also includes a role as a Research Assistant at Indiana University Bloomington, conducting research on cannabinoid pharmacology.